Inlay

Profile

Head Department of Internal Medicine at Radboudumc, Nijmegen 🇳🇱. Professor fighting venous thromboembolism. Pregnancy, thrombosis, thrombophilia. Elected council member of ISTH. Feminist with ❤️ husband & 3 sons. 🚴🏼‍♀️🏃🏻‍♀️. #Hemesky #Thrombosky

Saskia Middeldorp

Congratulations to @isth.org Councilor @middeldorps.bsky.social on being named & delivering the 2025 Sol Sherry Disting. Lecture in Thrombosis @ the recent @americanheart.bsky.social Scientific Sessions recognizing her role as a foremost clinician & researcher in the field of CV disease & stroke!

📰 Check it out! The @ash.hematology.org and ISTH Updated Guidelines on the Treatment of Pediatric VTE are featured in Hematology Advisor. Don’t miss this spotlight on our collaborative effort! 📖 Read the full feature: www.hematologyadvisor.com/news/pediatr... #PediatricVTE #Hematology #ISTH

What an inspiring #ISTH2025! It was wonderful to host the global #thrombosis & #hemostasis community in DC. From the latest science & innovations to networking & building new collabs - it had it all! Look out for recordings & other post- @isth.org congress updates. Goodbye & see you @ #ISTH2026!

#ISTH2025

Marc Rodger highlighting the #Highlow study and providing guidance on how to implement the results 👌🏼

Now my favourite topic presented eloquently by prof Marc Rodger. Answering all the questions needed for providing well-informed information to your patients. Put the #LMWH needles away in patients with placenta-mediated complications in inherited #thrombophilia! #AFFIRM #ALIFE2 #ISTH2025

It took 7 years to recruit 51 patients for the IMPACT single-arm study on certiluzomab on top of LMWH-aspirin shows adverse outcome in 20% which is lower than non-contemporary controls. #ISTH2025

More on pregnancy and #APS, now from obstetric perspective. Only 1% of recurrent miscarriage patients had APS antibodies, similar to controls. #ISTH2025

Implementation matters! A guideline-driven VTE prevention program (Vermont Model) led to ~60% of high-risk cancer patients receiving prophylactic anticoagulation—resulting in a 60% reduction in VTE and 56% reduction in death. #ISTH2025 #VTEprevention 🩸 @marycushmanmd.bsky.social

Why do we have so little data on pregnancy and thrombotic outcomes in #APS?? Well-illustrated by State-of-the-Art lecture by dr Karen Breen. We MUST do better! #ISTH2025

7mo